Enhanced Local Delivery of Engineered IL-2 mRNA by Porous Silica Nanoparticles to Promote Effective Antitumor Immunity
- 29 August 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (17) , 17554-17567
Abstract
Localized expression of immunomodulatory molecules can stimulate immune responses against tumors in the tumor microenvironment while avoiding toxicities associated with systemic administration. In this study, we developed a polyethylenimine-modified porous silica nanoparticle (PPSN)-based delivery platform carrying cytokine mRNA for local immunotherapy in vivo. Our delivery platform was significantly more efficient than FDA-approved lipid nanoparticles for localized mRNA translation. We observed no off-target translation of mRNA in any organs and no evidence of systemic toxicity. Intratumoral injection of cytokine mRNA-loaded PPSNs led to high-level expression of protein within the tumor and stimulated immunogenic cancer cell death. Additionally, combining cytokine mRNA with an immune checkpoint inhibitor enhanced anticancer responses in several murine cancer models and enabled the inhibition of distant metastatic tumors. Our results demonstrate the potential of PPSNs-mediated mRNA delivery as a specific, effective, and safe platform for mRNA-based therapeutics in cancer immunotherapy.Keywords
Funding Information
- Lemonex Inc.
This publication has 53 references indexed in Scilit:
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumorsJournal of Clinical Investigation, 2013
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and ImmunotherapyImmunity, 2013
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’Nature, 2012
- The role of interleukin-2 during homeostasis and activation of the immune systemNature Reviews Immunology, 2012
- Cancer immunotherapy comes of ageNature, 2011
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and ImmunityImmunity, 2010
- Breaking up the correlation between efficacy and toxicity for nonviral gene deliveryProceedings of the National Academy of Sciences, 2007
- Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporationCancer Gene Therapy, 2006
- Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8Science, 2004
- Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNAScience, 2004